Veritas In Silico Inc. (TYO:130A)
Japan · Delayed Price · Currency is JPY 433.00
+7.00 (1.64%)
Oct 6, 2026, 3:30 PM JST
Veritas In Silico Market Cap
Veritas In Silico has a market cap or net worth of 2.81 billion as of October 6, 2026. Its market cap has decreased by -38.05% in one year.
Market Cap
2.81B
Enterprise Value
1.38B
Revenue
84.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
433.00
ChartMarket Cap Chart
Since February 8, 2024, Veritas In Silico's market cap has decreased from 15.76B to 2.81B, a decrease of -82.18%. That is a compound annual growth rate of -47.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 2.81B | -9.79% |
| Dec 30, 2025 | 3.11B | -45.58% |
| Dec 30, 2024 | 5.72B | -63.69% |
| Feb 8, 2024 | 15.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Noile-Immune Biotech | 5.08B |
| Kringle Pharma | 4.73B |
| Chordia Therapeutics | 4.71B |
| Ribomic | 4.30B |
| D. Western Therapeutics Institute | 4.26B |
| Kohjin Bio | 4.21B |
| Transgenic Group | 4.03B |
| Modalis Therapeutics | 3.41B |